• Can This ‘SkinGun’ Help Burn Victims Heal Faster?

    New York-based RenovaCare has designed a device to treat patients with second-degree burns using their own stem cells.Nancy CrottiRenovaCare is seeking FDA clearance for this SkinGun to spray burn victims with their own stem cells. Patients with severe second-degree burns were able to leave the hospital within days of treatment with their own stem cells, sprayed by a New York company’s “skin gun,” according to a study.Learn about user-centered design at MD&M East, June 13-15, 2017, in...
  • MD&M East 2017 Innovation Prize Official Rules

    NO PURCHASE OR PAYMENT OF ANY KIND IS NECESSARY TO ENTER OR WIN. A PURCHASE OR PAYMENT WILL NOT IMPROVE YOUR CHANCES OF WINNING. CONTEST IS VALID ONLY IN THE UNITED STATES (EXCLUDING PUERTO RICO) AND CANADA (EXCLUDING QUEBEC) – ENTRIES FROM PERSONS LIVING IN OTHER COUNTRIES WILL BE AUTOMATICALLY DISQUALIFIED. GENERAL CONDITIONS:The MD&M East 2017 Innovation Prize (the “Contest”) is sponsored by UBM LLC, 2901 28th St., Ste. 100, Santa Monica, CA 90405 (“UBM...
  • Call for Entries: MD&M East 2017 Innovation Prize

    If you'll be showcasing an innovative medtech product or service at the upcoming Medical Design & Manufacturing East expo June 13–15 (or at any of its co-located shows), enter our contest for a chance to be included in a special innovation tour for attendees. Entries are due May 17, 2017.UBM is looking to identify the most innovative exhibitors at Medical Design & Manufacturing East 2017 (or at any of its co-located shows) and give them the recognition they...
  • How a Womb-Like Device Could Save Premature Babies

    Pediatric researchers design an innovative new fluid-filled device that can mimic the prenatal environment that newborns need for organ development. Kristopher Sturgis Researchers at the Children's Hospital of Philadelphia are developing a womb-like device that has already been tested on fetal lambs. The system could provide pre-mature infants with a fluid-filled environment to finish developing vital organs.   Pediatric researchers from the Children’s Hospital of...
  • How a Former Medtronic Rep Wants to Liberate Clinicians

    A former Apple product manager and Medtronic sales rep has launched his own company, Murj Inc., to liberate clinicians from paper processes and inefficient device management tools using digital health technology.Amanda Pedersen Todd Butka’s resume has two key details that set him apart from other medtech entrepreneurs: his experience as a product development manager for Apple, and his experience as a sales representative for the largest pure-play medical device company in the world,...
  • Cardiovascular Systems Socked with $25M in Whistleblower Verdict

    A California jury awarded $25.1 million to a former sales manager who claimed the company gave kickbacks to physicians, promoted off-label products, and retaliated against him for reporting the information to management.Nancy Crotti  A Los Angeles jury has awarded a former Cardiovascular Systems Inc. (CSI) regional sales manager $25.1 million in damages in a whistleblower retaliation suit.Learn from industry experts about product label design, risk management, and more at the MD&M...
  • How to Create Wearables People Actually Want to Use

    p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 11.0px Helvetica} span.s1 {font-kerning: none} As the healthcare industry continues to embrace wearable technology, product developers are challenged to design medical-grade devices that are small and unobtrusive enough for people to actually use, while also powerful enough to collect and send data in a way that is actionable.Amanda PedersenMC10's BioStampRC enables study subjects to go about heir daily routine while the device captures data,...
  • Can Boston Scientific Woo More Women into Clinical Trials?

    A Boston Scientific pilot program, recently initiated within two large cardiovascular device trials, could help the industry better understand why more women don’t enroll in clinical trials, and how to knock down those barriers.Amanda PedersenBoston Scientific recently launched the MADIT S-ICD study to assess sudden cardiac arrest prevention therapy in patients with diabetes who have previously experienced a heart attack. MADIT S-ICD is one of two cardiovascular device trials in which the...
  • Edwards’ Stellar U.S. TAVR Performance Result of ‘Several Small Things’

    Edwards Lifesciences posted U.S. transcatheter aortic valve revenue that impressed industry analysts. Here are the factors that buoyed sales and what management expects for the near future.Marie ThibaultNumerous factors, including faster growth from new hospitals, drove Edwards Lifesciences’ strong first quarter U.S. transcatheter aortic valve replacement (TAVR) sales. Management from the TAVR giant pointed to “several small things” that helped boost sales of its Sapien TAVR platform.“Overall,...
  • A New ‘Force’ in Injectable Drug Delivery

    A new approach to delivering injections could ease administration and open up design possibilities.Daphne AllenDeveloping delivery devices for injectable drugs has never been as challenging as it is today. Thanks to changing healthcare models, a growing number of patients are being asked to self-administer therapies for cancer, arthritis, multiple sclerosis, and other chronic illnesses. But patients aren’t professionals. “Patients who will need to take injections are not familiar with using a...
  • And the XPRIZE Goes to . . .

    A Pennsylvania-based team invented a diagnostic tool inspired by Star Trek and landed millions of dollars to bring it to market. Nancy CrottiFinal Frontier Medical Devices won the Qualcomm Tricorder XPRIZE for its DxtER prototype device. A family of engineers and doctors has taken their commitment to science and technology, and devotion to a futuristic TV show, to boldly go where no one has gone before—they invented an actual Tricorder.Final Frontier Medical Devices, made up of...
  • Should BD Investors Get Over Their Bard Sticker Shock?

    Becton, Dickinson and Company (BD) gave a lot of shareholders sticker shock Sunday with the news of its $24 billion pending acquisition of C.R. Bard Inc. But this isn’t BD’s first blockbuster M&A rodeo, and both management teams painted a pretty interesting picture of what the combined entity could look like.Amanda Pedersen It’s easy to understand why investors would have a case of sticker shock over the news of Becton, Dickinson and Company’s (BD) $24 billion pending acquisition of C....
  • Are Ingestible Sensors the Answer to Medication Adherence Problems?

    Digital medicine, with an ingestible sensor at its core, could go a long way toward improving medication adherence.Andrew Kelly Proteus Discover, developed by Proteus Digital Health, is designed to improve medical adherence using ingestible sensors, a wearable device, and mobile technology.“Drugs don’t work in patients who don’t take them.”  According to former Surgeon General C. Everett Koop, the medication adherence problem is simple and obvious. The solution, unfortunately, is not...
  • How J&J is Boning Up on 3-D Printing

    Johnson & Johnson’s DePuy Synthes has acquired an early-stage 3-D printing technology aimed at healing bone defects.Amanda PedersenThe industry has only just scratched the surface of bringing 3-D printing into the medical arena, but a recent Johnson & Johnson acquisition is an indicator of the ultimate promise the technology holds for medtech. Find out which emerging technologies physicians and hospitals are excited about at the BIOMEDevice Boston Conference, May 3-4, 2017.J&J'...
  • Could One Test Help Combat a Massive Problem?

    MeMed Ltd has been awarded a $9.2M Department of Defense contract to support a rapid point-of-care test designed to distinguish between bacterial and viral infections, ultimately helping to mitigate the misuse of antibiotics.Kristopher SturgisMeMed's second-generation point-of-care test is designed to distinguish between bacterial and viral infections within 15 minutes. The technology could play an important role in the global fight against antibacterial drug resistance. A relatively new...
  • Measure Biomarkers with a Wearable Device? No Sweat

    Researchers have built a device to induce perspiration and measure health indicators like blood glucose on demand.Nancy CrottiThis wearable device, developed by Stanford University researchers, is designed to extract and analyze sweat to monitor health and disease. Many of the biomarkers clinicians gain access to through a blood draw can actually be quantified in sweat itself. However, it’s neither easy, nor necessarily advisable, to make sedentary or critically ill patients work up a...
  • Lower Volume, Value for Recent Med Device M&A

    In the medical device subsector, both the volume and total value of deals in the first quarter of 2017 were lower than in the prior and year ago quarters.Marie ThibaultVenture capital funding for medical device companies may have rallied during the first quarter of 2017, but deal volume and value for mergers and acquisitions for the medtech industry declined during the same time period.Deal value for life sciences mergers and acquisitions announced in the first quarter of 2017 rose, according...
  • Will Abbott Be Able to Fix-and-Flip Alere?

    Abbott CEO Miles White sees Alere as “a fixer-upper,” and said the company will divest some parts of the business after the amended deal closes.Amanda Pedersen Abbott CEO Miles White isn’t one to tiptoe around the elephant in the room. So, when it came time for questions during the company’s first-quarter earnings call Wednesday, White was ready to talk about Alere.“Look, the company had some challenges, we all know that, and it’s a bit of a fixer-upper,” he said.Learn about the latest...
  • How Abbott is 'All Over Everything' in FDA Warning

    Abbott CEO Miles White told investors that the company is "all over everything" in its recent FDA warning letter, and that the company will be looking at all of its manufacturing plants, not just the Sylmar, CA-based facility addressed in the letter.Amanda Pedersen Abbott Laboratories smashed first-quarter sales and profit expectations after acquiring St. Jude Medical in early January, but the company’s strong financial performance was overshadowed Wednesday by questions related to a...
  • The Latest on J&J’s Device Strategy

    Johnson & Johnson executives offer insights into their view for the company’s medical device business, which is undergoing a transformation.Marie ThibaultJohnson & Johnson’s latest medical device transactions pale in size compared to the company’s $30 billion deal to pick up Actelion and its 2012 $20 billion acquisition of Synthes. Is there any potential for Johnson & Johnson to go after a large device acquisition?The healthcare giant has announced a few medical device acquisitions...